Core contributor to ENRICHME (robot-assisted elderly care), CYBERLEGs Plus Plus (cognitive lower-limb ortho-prosthesis), and DECI (digital cognitive inclusion).
FONDAZIONE DON CARLO GNOCCHI ONLUS
Italian rehabilitation research foundation specializing in assistive robotics, neurorehabilitation, and ethical assessment of health technologies for patient care.
Their core work
Fondazione Don Carlo Gnocchi is an Italian non-profit research and rehabilitation foundation headquartered in Milan, specializing in assistive technologies, neurorehabilitation, and care for people with disabilities and the elderly. They bring clinical rehabilitation expertise into EU research projects focused on robotics-assisted living, cognitive ortho-prosthetics, and disorders of consciousness. Their work bridges the gap between medical technology development and real-world patient care, contributing clinical validation, user needs assessment, and ethical evaluation of emerging health technologies. They also play an active role in translating nanomedicine and smart systems innovations toward clinical and industrial adoption.
What they specialise in
DoCMA focused specifically on diagnosis, prognosis, and brain stimulation for disorders of consciousness; DECI addressed cognitive inclusion through digital environments.
ENATRANS and NOBEL both targeted ecosystem building and innovation pathways to bring nanomedicine and key enabling technologies from lab to clinic.
ETAPAS (2020-2023) focused on ethical technology adoption in public services, covering AI, robotics, and digital governance.
EURIPHI addressed pre-commercial procurement and value-based healthcare approaches for integrated care and rapid diagnostics.
How they've shifted over time
In their early H2020 period (2015-2017), the foundation focused on translating medical technologies to clinical use and deploying assistive robotics for elderly care — keywords like "residential care," "gerontology," "bridge to clinics," and "long term human robot interaction" dominated. From 2018 onward, their focus shifted toward ecosystem-level activities (innovation ecosystems, smart systems integration) and broader societal questions around ethics of technology, digital governance, and responsible AI adoption. This evolution suggests a move from hands-on clinical technology development toward strategic and policy-oriented roles in health-tech innovation.
They are increasingly positioning themselves at the intersection of health technology and responsible digital innovation, making them a strong partner for projects requiring ethical assessment and patient-centered technology validation.
How they like to work
Fondazione Don Carlo Gnocchi operates exclusively as a participant — they have never coordinated an H2020 project, preferring to contribute specialized clinical and rehabilitation expertise within larger consortia. With 101 unique partners across 19 countries in just 9 projects, they connect broadly rather than deeply, joining diverse teams rather than returning to the same partners repeatedly. This pattern suggests they are valued as a reliable domain expert that consortia seek out for clinical validation and end-user perspectives.
With 101 unique consortium partners across 19 countries from 9 projects, they maintain a wide European network concentrated in health technology, rehabilitation, and digital innovation. Their Milan base connects them well to Southern European research ecosystems while their partner diversity spans the continent.
What sets them apart
What sets Fondazione Don Carlo Gnocchi apart is their combination of being a clinical rehabilitation provider AND a research organization — they don't just develop technologies, they test and deploy them with real patients in real care settings. Their non-profit status and decades of experience in disability and elderly care give them credibility in user-centered design and ethical assessment that purely academic or industrial partners cannot match. For consortium builders, they offer a rare package: clinical facilities, patient access, rehabilitation expertise, and growing competence in responsible innovation governance.
Highlights from their portfolio
- CYBERLEGs Plus PlusTheir largest funded project (EUR 478,250) developing a cognitive lower-limb ortho-prosthesis — represents their deepest investment in rehabilitation robotics.
- DoCMAA Marie Curie staff exchange running until 2023, focused on disorders of consciousness — signals sustained commitment to building international expertise in a highly specialized clinical area.
- ETAPASTheir most recent project (2020-2023) on ethical AI adoption in public services marks a strategic pivot toward digital governance and responsible technology.